Manhattan, KS, United States of America

John M Tomich

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1999-2022

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of John M Tomich

Introduction

John M Tomich is a prominent inventor based in Manhattan, Kansas, known for his significant contributions to the field of biotechnology. With a total of 10 patents to his name, he has made remarkable advancements in the development of nucleic acid-peptide complexes and multifunctional metallic nanoparticle systems. His work has the potential to revolutionize the delivery of genetic materials in various applications.

Latest Patents

One of his latest patents is focused on nucleic acid-peptide capsule complexes. This invention describes nanoparticles that consist of pre-formed peptide capsules with nucleic acids bound to their exterior surface. The design allows for effective delivery of nucleic acids both in vivo and in vitro. Another notable patent involves multifunctional metallic nanoparticle-peptide bilayer complexes. This innovation features nanoparticulates with a metallic core encapsulated by a peptide shell. The self-assembly of branched, amphipathic peptides creates a unique interlocking structure that enhances the functionality of the nanoparticles.

Career Highlights

John M Tomich is affiliated with the Kansas State University Research Foundation, where he continues to push the boundaries of research in his field. His work has garnered attention for its innovative approach to solving complex problems in biotechnology.

Collaborations

He has collaborated with notable colleagues such as Takeo Iwamoto and James R Broughman, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

John M Tomich's contributions to the field of biotechnology through his patents and research collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in the delivery of nucleic acids and nanoparticle technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…